½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1481417

¼¼°èÀÇ ÁöÇ÷ Á¦Ç° ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº° - »ê¾÷ ¿¹Ãø(2024-2031³â)

Global Hemostasis Products Market Size, Share, Growth Analysis, By Product(Topical Hemostasis Products, Infusible Hemostasis Products), By Application(Trauma, Surgery), By End-user(Hospitals, Clinics) - Industry Forecast 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 219 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÁöÇ÷ Á¦Ç° ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 16¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2023³â 16¾ï 9,000¸¸ ´Þ·¯¿¡¼­ 2031³â¿¡´Â 25¾ï 9,000¸¸ ´Þ·¯·Î ¼ºÀåÇϸç, ¿¹Ãø ±â°£(2024-2031³â)ÀÇ CAGRÀº 5.5%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÁöÇ÷Á¦ ½ÃÀåÀº ÀÇ·á ±â¼úÀÇ Çâ»ó°ú ÀǽÄÀÇ Çâ»ó¿¡ ÀÇÇØ ¼¼°è ±Ô¸ð·Î ²ÙÁØÈ÷ È®´ëÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ ÀǾàÇ°Àº ¼ö¼úÈÄ ¹× ¿Ü»óÈÄ ÁöÇ÷»Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ ÃâÇ÷ ¹®Á¦ÀÇ °ü¸®¿¡µµ ÇʼöÀûÀÔ´Ï´Ù. ÁöÇ÷Á¦ ½ÃÀåÀº Àα¸ °í·ÉÈ­, ¸¸¼ºÁúȯÀÇ Áõ°¡, ¼ö¼ú °Ç¼öÀÇ Áõ°¡¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³¹ßµµ»ó±¹¿¡¼­ ÇコÄÉ¾î ½Ã¼³ÀÇ ÀÌ¿ë ¿ëÀ̼ºµµ ¾÷°èÀÇ È®´ë¸¦ Áö¿øÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áö¼ÓÀû ¿¬±¸°³¹ß ³ë·Â¿¡ ÀÇÇØ »õ·Î¿î ÁöÇ÷ Á¦Ç°ÀÌ ¹ß¸ÅµÇ¸ç À¯È¿¼º°ú ¾ÈÀü¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ Á¦Ç°Àº °í°¡À̸ç, ±ÔÁ¦»ó Àå¾Öµµ ÀÖÀ¸¹Ç·Î ¾÷°èÀÇ È®´ë°¡ ÀúÇØµÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àå¾Ö¿¡µµ ºÒ±¸ÇÏ°í ¼¼°èÀÇ ÁöÇ÷Àç ½ÃÀåÀº ÇコÄÉ¾î ±âÁØ ¹× ±â¼úÀÌ Áøº¸ÇÏ´Â °Í¿¡ µû¶ó È®´ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • Wheel of Fortune

Á¶»ç ¹æ¹ý

  • Á¤º¸ Á¶´Þ
  • 2Â÷ µ¥ÀÌÅÍ ¼Ò½º¿Í 1Â÷ µ¥ÀÌÅÍ ¼Ò½º
  • ½ÃÀå ±Ô¸ð ¿¹Ãø
  • ½ÃÀåÀÇ À§±â¿Í ÇÑ°è

¸ð½ÃÀå ºÐ¼®

  • ½ÃÀå °³¿ä
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ±âȸ
    • ¾ïÁ¦¿äÀÎ
    • °úÁ¦

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • ±â¼ú ºÐ¼®
  • °¡°Ý ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • ½ÃÀåÀÇ ¿¡ÄڽýºÅÛ
  • IP ºÐ¼®
  • ¹«¿ª ºÐ¼®
  • ½ºÅ¸Æ®¾÷ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
  • Çõ½Å ¸ÅÆ®¸¯½º
  • ÆÄÀÌÇÁ¶óÀÎ Á¦Ç° ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥
  • ÁÖ¿ä ÅõÀÚÀÇ ºÐ¼®
  • ÁÖ¿ä ¼º°ø¿äÀÎ
  • °æÀïÀÇ Á¤µµ

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ±âȸ
    • ¾ïÁ¦¿äÀÎ
    • °úÁ¦
  • ±ÔÁ¦ »óȲ
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • ÇâÈÄ È¥¶õ¿¡ °üÇÑ Æ¯º° ÀλçÀÌÆ®

¼¼°èÀÇ ÁöÇ÷ Á¦Ç° ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå °³¿ä
  • ±¹¼Ò ÁöÇ÷ Á¦Ç°
  • ¼ö¾× ÁöÇ÷ Á¦Ç°
  • ÷´Ü ÁöÇ÷ Á¦Ç°

¼¼°èÀÇ ÁöÇ÷ Á¦Ç° ½ÃÀå : ¿ëµµº°

  • ½ÃÀå °³¿ä
  • Æ®¶ó¿ì¸¶
  • ¼ö¼ú
  • Ç÷¿ìº´
  • ½É±Ù°æ»ö

¼¼°èÀÇ ÁöÇ÷ Á¦Ç° ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå °³¿ä
  • º´¿ø
  • Ŭ¸®´Ð
  • ±âŸ

¼¼°èÀÇ ÁöÇ÷ Á¦Ç° ½ÃÀå ±Ô¸ð : Áö¿ªº°

  • ½ÃÀå °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
    • GCC ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï ±¸µµ

  • »óÀ§ 5»çÀÇ ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2023³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ÁÖ¿ä ¼º°ø Àü·«
  • ½ÃÀå¿¡¼­ÀÇ ÃÖ±Ù È°µ¿
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²(2023³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • Johnson & Johnson(US)
  • Pfizer(US)
  • Baxter International(US)
  • Medtronic(US)
  • B. Braun Melsungen AG(Germany)
  • Becton, Dickinson, and Company(BD)(US)
  • Tricol Biomedical(US)
  • Hemostasis LLC(US)
  • CuraMedical BV(Netherlands)
  • Teleflex Incorporated(US)
  • CryoLife, Inc.(US)
  • Ethicon, Inc.(US)
  • Grifols, S.A.(Spain)
  • Terumo Corporation(Japan)
  • Integra LifeSciences Holdings Corporation(US)
  • HemCon Medical Technologies, Inc.(US)
  • Zimmer Biomet Holdings, Inc.(US)
  • Haemonetics Corporation(US)
  • CSL Behring LLC(Australia)
  • Olympus Corporation(Japan)
KSA 24.05.28

Global Hemostasis Products Market size was valued at USD 1.60 billion in 2022 and is poised to grow from USD 1.69 billion in 2023 to USD 2.59 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).

The market for hemostasis products is expanding steadily on a global scale as a result of rising awareness and improvements in medical technology. These medicines are essential for managing a variety of bleeding problems as well as for stopping bleeding after surgery and trauma cases. The market for hemostasis products is being driven by an aging population, an increase in chronic diseases, and an increase in surgeries. The growing accessibility of healthcare facilities in developing nations is also fostering industry expansion. In addition, continuous R&D endeavors are resulting in the launch of novel hemostasis products, augmenting their effectiveness and safety. The expensive cost of these items and regulatory obstacles, however, may prevent the industry from expanding. Notwithstanding these obstacles, the market for hemostasis products worldwide is expected to grow as healthcare standards and technologies advance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis Products Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis Products Market Segmental Analysis

The global hemostasis products market is segmented on the basis of product, application, end-user, and region. Based on product, the market is segmented as Topical Hemostasis Product, Infusible Hemostasis Products, and Advanced Hemostasis Products. On the basis of application, the market is segmented into Trauma, Surgery, Hemophilia, Myocardial Infarction. Based on the end-user, it is segregated into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Hemostasis Products Market

The treatment of bleeding problems and surgical operations are being significantly improved by innovations like the development of more environmentally friendly and safe hemostasis products, in addition to hemostatic agents and devices. These upgrades enhance patient outcomes and put pressure on a rise in the market.

Restraints in the Global Hemostasis Products Market

One of the most notable commercial constraints is the high price of hemostasis products. These products may be expensive, which limits their availability to patients in some areas and healthcare facilities with limited funding. The cost factor may prevent the widespread use of better hemostasis solutions, limiting their market penetration and possibly impairing patient care.

Market Trends of the Global Hemostasis Products Market

Both patients and healthcare organizations are looking for less intrusive ways to treat bleeding problems and surgical procedures. This movement makes use of the advancements in progressive hemostasis products and methods, which lessen tissue damage, speed up repair, and improve average patient outcomes. Due to its potential to improve patient comfort and reduce hospital stays, minimally invasive hemostasis techniques are gaining popularity. This trend is in line with the healthcare industry's emphasis on value-based treatment.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Hemostasis Products Market by Product

  • Market Overview
  • Topical Hemostasis Products
  • Infusible Hemostasis Products
  • Advanced Hemostasis Products

Global Hemostasis Products Market by Application

  • Market Overview
  • Trauma
  • Surgery
  • Hemophilia
  • Myocardial Infarction

Global Hemostasis Products Market by End-user

  • Market Overview
  • Hospitals
  • Clinics
  • and Others

Global Hemostasis Products Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson, and Company (BD) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tricol Biomedical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hemostasis LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CuraMedical BV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CryoLife, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ethicon, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Grifols, S.A. (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Holdings Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HemCon Medical Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haemonetics Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CSL Behring LLC (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦